Geneva, May 4 -- International Clinical Trials Registry received information related to the study (TCTR20260424014) titled 'The Impact of Allergen Sensitization on Quality of Life in Adult Atopic Dermatitis: A Cross-Sectional Study in Southern Thailand' on April 24.
Study Type: Observational
Primary Sponsor: Fundamental Fund (FF)
Condition:
Atopic Dermatitis (AD)
Atopic Dermatitis, Dermatology Life Quality Index, Specific IgE
Atopic Dermatitis, Dermatology Life Quality Index, Specific IgE
Intervention:
Adult patients aged 18 years or older who have been diagnosed with atopic dermatitis by a physician and present with acute, subacute, or chronic skin inflammation.
Screening
Recruitment Status: Not Recruiting
Date of First Enrollm...